Danish Researchers Study Non-Specific Vaccine Effects in Guinea-Bissau
Peter Aaby and Christine Stabell Benn have conducted vaccine research in Guinea-Bissau for decades. Their findings on non-specific effects have drawn renewed attention under the current U.S. administration. The work has prompted both funding and criticism from Danish scientists.
WiredThey reported that live vaccines such as measles and tuberculosis shots appeared to reduce overall child mortality beyond protection against those specific diseases. They also reported that inactivated vaccines such as the diphtheria-tetanus-pertussis shot were associated with higher mortality in some groups.
The researchers published these observations in multiple papers over many years. The World Health Organization reviewed the findings but did not change its vaccine recommendations. Other scientists noted that the results were difficult to replicate and that the methods differed from standard approaches.
Health and Human Services awarded the Bandim group $1.6 million to study whether the birth dose of hepatitis B vaccine affects immune systems or causes neurological issues. The study plans to withhold the vaccine from half of 14,000 newborns in Guinea-Bissau.
The World Health Organization and some infectious disease specialists have stated that withholding the dose is unethical given high hepatitis B prevalence in the country. Kennedy Jr. cited one of the researchers' papers when announcing a $2.6 billion cut in U.S. support for Gavi.
The agency estimated the reduction could lead to 1.2 million preventable deaths over five years. A separate $600 million in current Gavi funding was also frozen.
Danish statisticians and infectious disease experts have published articles in the past 18 months questioning the methods used by Aaby and Benn. A national scientific board is investigating the work. Lone Stensballe, who previously collaborated with the pair for 20 years, said their studies show a pattern of confirmation bias.
Anders Hviid, chief epidemiologist at Statens Serum Institut, said Benn does not influence Danish vaccine policy. Danish authorities continue to follow their existing vaccine schedule, which includes inactivated vaccines. The researchers did not respond to requests for comment on the current developments.
Key Facts
Story Timeline
5 events- 2023
Researchers published review calling for updated vaccine testing framework.
1 sourceWired - December
HHS awarded $1.6 million to Bandim group for hepatitis B vaccine study.
1 sourceWired - January
U.S. vaccine schedule changes took effect before being temporarily blocked.
1 sourceWired - March 16
Federal judge temporarily blocked U.S. vaccine schedule changes.
1 sourceWired - May 15
Tracy Beth Høeg was fired from FDA position.
1 sourceWired
Potential Impact
- 01
The $2.6 billion funding cut could reduce vaccination programs in low-income countries.
- 02
The hepatitis B vaccine study may face continued ethical review by Danish and international bodies.
- 03
Danish health authorities may maintain their current vaccine schedule despite U.S. policy shifts.
Transparency Panel
Related Stories
straitstimes.comJournalists in Gaza to Receive 2026 Golden Pen of Freedom Award
Three international news agencies will accept the award on behalf of their local staff still reporting from the territory. The World Association of News Publishers cited the journalists' continued coverage under extreme conditions.
upi.comSupreme Court Revives Havana Docks Lawsuit Over Confiscated Cuban Property
The U.S. Supreme Court sent a Helms-Burton Act case back to lower courts for further argument. The suit seeks damages from cruise lines that used docks seized by Cuba in 1959.
France 24Pakistan Population Growth Outpaces Infrastructure as Male Contraception Stays Taboo
Pakistan's population exceeds 258 million and could reach 300 million by 2030. Contraception remains largely taboo in a society shaped by traditional values. The country continues to lag behind neighbors India and Bangladesh in key social sectors.